Content
Lyft Expects To Raise Up To $2.1 Billion As IPO Roadshow Begins
Article By:
Tyler Durden
Read
Monday, March 18, 2019 8:28 AM EDT
Lyft is looking to raise up to $2.1 billion in its upcoming initial public offering.
In this article: LYFT
Qutoutiao Could Dip When IPO Lockup Expires
Week In Review: Nanjing's NJCTTQ Agrees To $4 Billion Package For Abpro Bi-Specific Immunotherapies
Article By:
ChinaBio® Today
Read
Saturday, March 2, 2019 4:14 PM EDT
NJCTTQ, a Nanjing biopharma, announced a deal worth up to $4 billion to co-develop bispecific immunotherapies discovered by Abpro of Massachusetts.
Uber Vs Lyft: Here Are The Highlights From Lyft's IPO Filing
Article By:
Tyler Durden
Read
Friday, March 1, 2019 5:23 PM EDT
Uber's biggest competitor Lyft finally filed its long-awaited IPO application giving potential investors a first look at the company's financial information as it hopes to become the first the ride-sharing giant to go public.
In this article: LYFT
Week In Review: CStone's Hong Kong IPO To Raise $304 Million At $1.5 Billion Valuation Next Week
Article By:
ChinaBio® Today
Read
Saturday, February 16, 2019 8:30 PM EDT
China will reduce the Value Added Tax on 21 rare disease treatments to 3%, starting March 1. Plus: an IPO, financings, licensing, funding rounds.
In this article: MCHI
Week In Review: New Shanghai Hi-Tech Exchange To IPO Pre-Revenue Companies
Article By:
ChinaBio® Today
Read
Saturday, February 2, 2019 4:41 PM EDT
The Shanghai Stock Exchange's new Technology Innovation Board will allow still-unprofitable hi-tech companies - including biopharmas - to IPO on the exchange, though each company that debuts must have a valuation of at least $600 million to qualify.
Week In Review: 2018 Results: China Life Science Investment Hits Record Levels
Article By:
ChinaBio® Today
Read
Saturday, January 5, 2019 4:28 PM EDT
Investments in China life science set new records in all categories during 2018, reflecting the increasing development of the industry. And these numbers are spectacular even in comparison to an already strong 2017.
Biotech Bonanza: 2019 Outlook
Article By:
Tarun Chandra, CFA
Read
Tuesday, January 1, 2019 1:04 PM EDT
In 2019 biotech stocks will have an uphill battle, but will still provide opportunities for attractive gains.
In this article: IBB, SPY, XBI, XLV, MRNA, TSRO Also: AGN, BMY, JNJ, MRK, NVS, PFE, AMGN, LLY, AZN, GSK, ALXN, REGN, CVS, ESRX, VRTX
Week In Review: Shanghai Industrial To Start $7.3 Billion Biomedical Fund In 2019
Article By:
ChinaBio® Today
Read
Saturday, December 29, 2018 4:08 PM EDT
Shanghai Industrial Investment, a state-owned conglomerate, plans to launch a $7.3 billion equity fund for China biopharma investments. The company plans to begin raising $1.5 billion in January for the fund's first tranche.